Re: COVID 19 HAIKU
Posted: Fri May 07, 2021 11:26 am
https://anthraxvaccine.blogspot.com/
Friday, May 7, 2021
The Vaccine Lies that Bind: FDA, EBS, J and J and the regulators of the EU, South Africa, Canada and Mexico
I have repeatedly warned about vaccine that might have illegally sneaked out the back door of the Emergent BioSolutions Bayview Baltimore plant.
How did Emergent-made J and J vaccine, from a factory that was out of GMP compliance on every single one of its FDA inspections, and never received authorization to ship out vaccine for Americans, find its way to Europe, South Africa, Canada and Mexico?
How does that happen? When did it happen?
And since it did happen, why would I believe no Americans got the vaccine? What was FDA's role in this fiasco?
Here's what the FDA's acting Commissioner said on April 21, breaking FDA's long silence about whether the plant was authorized or not:
"... the FDA has not authorized this facility to manufacture or distribute any of Johnson & Johnson’s COVID-19 Vaccine or components and, to date, no COVID-19 vaccine manufactured at this plant has been distributed for use in the U.S..."
Remember, this is not simply about mixing up an ingredient between the Astra-Zeneca and Johnson and Johnson vaccines. There were many, many problems that led to the loss of millions more doses. The plant was maintained in a slovenly fashion. You can read the latest FDA inspection report here. An April 21 NY Times article summarized the findings:
A series of confidential audits last year, obtained by The Times, warned about risks of viral and bacterial contamination and a lack of proper sanitation at the Baltimore plant.
According to the May 6 NY Times:
The F.D.A. has now called into question the equivalent of about 70 million doses from the plant, most of it intended for domestic use, and may decide that none of that vaccine can be released in the United States, those officials said.
However:
Some doses from a single batch of the vaccine produced at Emergent are being administered in Europe, without problem, officials said. In addition, about six million to nine million more doses are now on hold there and in the other countries
Here is how the FDA's acting Commissioner tried to wriggle out of this mess. It sounds good at first:
For the vaccines already manufactured, the products will undergo additional testing and will be thoroughly evaluated to ensure their quality before any potential distribution. We will not allow the release of any product until we feel confident that it meets our expectations for quality.
But there is a big problem here. Not just the fact that somebody already did allow the release of product.
Testing finished vaccine lots cannot identify all the potential serious problems with vaccines. If it could, it would not matter what shape the factory was in, because you could simply test each lot and throw away any that were bad. The reason FDA plant inspections are so important is because product testing is insufficient to identify potential problems with vaccines.
I clearly recall a GAO report to Congress by Dr. Sushil Sharma about anthrax vaccine (that incidentally had also been made by EBS), which explained this point. What it means is that Janet Woodcock, the acting Commissioner, is attempting to mislead everyone by claiming that with additional testing, the lots produced while the plant was far out of compliance are not adulterated and can still be used.
The regulators in the other nations that received the bad lots of J and J vaccine repeated her identical, fallacious excuse.
While Dr. Woodcock is trying to cover her derriere (probably FDA knew about and approved the shipments of vaccine to other nations) there is no way either the FDA nor Emergent can squirm out of the hole they have dug for themselves.
From the NY Times:
Neither the F.D.A. nor its parent agency, the Department of Health and Human Services, would say what role, if any, the federal government played in the shipment of Johnson & Johnson doses abroad, or when and where they were shipped. White House officials did not respond to repeated requests for comment.
It is strange that after having failed so many prior inspections over 2 decades, Emergent BioSolutions was chosen to lead the US' response to Covid. It is slated to produce 4 vaccines and 5 other Covid medications.
In a statement to The New York Times, an F.D.A. spokeswoman said the agency was “in close communication with our foreign regulatory counterparts regarding this ongoing matter to ensure they’re aware of the situation...”
Does this mean FDA notified them of the May 6 NY Times revelations, informed them the jig was up, and they needed to come up with a uniform story?
Emergent referred questions to Johnson & Johnson and the F.D.A. “They control where the product goes after we manufacture it,” Matt Hartwig, a spokesman for the company, said in an email...
The European Union’s drug regulator, the European Medicines Agency, said in a statement to The Times that one batch of vaccine manufactured at the Emergent facility “is being used” after “a thorough testing of the batch and a review of the controls in place at the manufacturing site.” There is no indication of any problems with those doses.
That batch was distributed for use in the European Union only after meeting “the rigorous quality standards of our company and the European Medicines Agency,” Johnson & Johnson said in a statement...
Under its contract with Johnson & Johnson, Emergent manufactured the active ingredient for the vaccine in bulk, and the substance was then sent to other facilities for final processing and packaging...
The thing is, since Emergent knew it had not passed its inspections, it also knew its product could not be approved for use. So why did it ship it out for final bottling and finishing? Why did J and J collude with them to do so?
Everyone involved in this sordid tale has now gotten burned. It looks like there is plenty of blame to go around. The only thing missing is a prosecution.
The problem is pernicious secrecy. EBS, J and J, FDA and most likely the regulatory agencies of the EU, Canada, Mexico and South Africa had to have known there were problems with this vaccine. But they chose instead to look the other way, until their charade was uncovered by the New York Times.
And even after recipients started dying from blood clots and bleeding, the regulators, EBS and Johnson and Johnson kept the truth of the substandard vaccine they had released for use close to their chests.
And now the government regulators are still trying to fake us out by fancifully claiming they can test their way out of this. These same duplicitous apparatchiks were perfectly willing to inject trash into the arms of millions of their fellow citizens.
And already in Canada, and next week in the US, it might be injected into the waiting arms of 12 to 15 year olds.
Posted by Meryl Nass, M.D. at 12:36 AM 2 comments
Thursday, May 6, 2021
von der Leyen and the 4.1 billion doses/ NY Times
I am a week late getting this NYT article out. While the Times hints that von der Leyen bought the Pfizer vaccine for her political survival, the paper provides no evidence. My guess is that this is a cover story. You have to explain 4.1 billion doses for 448 million people some way. Politics is easy to blame.
The new contract will include a 900-million-dose order through 2023, with an option for another 900 million, Ms. von der Leyen said in an interview.
“I am convinced that we are in this for the long haul,” she said...
Accounts of how the deals came about, related by Ms. von der Leyen, Mr. Bourla, Mr. Marett and another nine officials and experts involved, reveal a striking alignment of political survival and corporate hustle...
Mr. Bourla said he built a bond with Ms. von der Leyen...
Mr. Bourla said he expected a booster would be needed six to twelve months after people get their second shot, although some public health experts note that it is not clear yet whether that will be necessary. And the assessment includes a worst-case scenario for a new vaccine to target an “escape mutant,” a variant of the coronavirus that is too resistant to existing shots. The draft says the European Union would require 640 million doses of this type of vaccine for two doses per adult...
Ms. von der Leyen said the European Union could still procure doses from other companies. [Yet more vaccine???]
She said the bloc was following the development of protein-based vaccines made by Novavax and Sanofi, as well as mRNA vaccines from Moderna, which are already being used in Europe, and CureVac, which is under review by the E.U. regulator. The Johnson & Johnson vaccine, which was rolled out in Europe this month, is also attractive because of its single-dose regimen and easy storage, she said.
The Pfizer shot is also expensive. While the financial details of the new agreement have not been disclosed, the previous contract priced the shot at approximately 15.5 euros, or about 19 dollars, making it the second-most expensive vaccine in the region after Moderna.
European Union members will each decide whether they want to use their full allocations of doses, or leave some for others to absorb, or to be resold or donated. They will also be free to make bilateral agreements with other pharmaceutical companies for vaccines in the future... [And even more possible vaccine]
Posted by Meryl Nass, M.D. at 9:11 PM 0 comments
It just makes sense: no Covid vaccine mandates until we actually know how safe the vaccine is, especially in the young/ Maine legislature
https://www.billtrack50.com/BillDetail/1338397
ME LD867
An Act To Prohibit Mandatory COVID-19 Vaccinations for 5 Years To Allow for Safety Testing and Investigations into Reproductive Harm
Views:
In the last
101
WEEK
86
MONTH
147
TOTAL
SUMMARY
BILL TEXT
ACTIONS
VOTES
DOCUMENTS
summary
Introduced
03/10/2021In Committee
03/10/2021Crossed OverPassedDead/Failed
Introduced Session
130th Legislature
Bill Summary
This bill prohibits mandatory vaccinations for coronavirus disease 2019 for 5 years from the date of a vaccine's first emergency use authorization by the United States Department of Health and Human Services, Food and Drug Administration in order to allow for safety testing and investigations into reproductive harm.
Subject
Health Care Services
Sponsors (8)
Tracy Quint (R)*, Susan Bernard (R), Amanda Collamore (R), Jonathan Connor (R), Joshua Morris (R), Heidi Sampson (R), Peggy Stanley (R), Harold Stewart (R),
Last Action
Carried over, in the same posture, to a subsequent special or regular session of the 130th Legislature, pursuant to Joint Order SP 435. (on 03/30/2021)
Official Document
http://legislature.maine.gov/legis/bill ... 7&snum=130
Posted by Meryl Nass, M.D. at 8:44 PM 0 comments
Friday, May 7, 2021
The Vaccine Lies that Bind: FDA, EBS, J and J and the regulators of the EU, South Africa, Canada and Mexico
I have repeatedly warned about vaccine that might have illegally sneaked out the back door of the Emergent BioSolutions Bayview Baltimore plant.
How did Emergent-made J and J vaccine, from a factory that was out of GMP compliance on every single one of its FDA inspections, and never received authorization to ship out vaccine for Americans, find its way to Europe, South Africa, Canada and Mexico?
How does that happen? When did it happen?
And since it did happen, why would I believe no Americans got the vaccine? What was FDA's role in this fiasco?
Here's what the FDA's acting Commissioner said on April 21, breaking FDA's long silence about whether the plant was authorized or not:
"... the FDA has not authorized this facility to manufacture or distribute any of Johnson & Johnson’s COVID-19 Vaccine or components and, to date, no COVID-19 vaccine manufactured at this plant has been distributed for use in the U.S..."
Remember, this is not simply about mixing up an ingredient between the Astra-Zeneca and Johnson and Johnson vaccines. There were many, many problems that led to the loss of millions more doses. The plant was maintained in a slovenly fashion. You can read the latest FDA inspection report here. An April 21 NY Times article summarized the findings:
A series of confidential audits last year, obtained by The Times, warned about risks of viral and bacterial contamination and a lack of proper sanitation at the Baltimore plant.
According to the May 6 NY Times:
The F.D.A. has now called into question the equivalent of about 70 million doses from the plant, most of it intended for domestic use, and may decide that none of that vaccine can be released in the United States, those officials said.
However:
Some doses from a single batch of the vaccine produced at Emergent are being administered in Europe, without problem, officials said. In addition, about six million to nine million more doses are now on hold there and in the other countries
Here is how the FDA's acting Commissioner tried to wriggle out of this mess. It sounds good at first:
For the vaccines already manufactured, the products will undergo additional testing and will be thoroughly evaluated to ensure their quality before any potential distribution. We will not allow the release of any product until we feel confident that it meets our expectations for quality.
But there is a big problem here. Not just the fact that somebody already did allow the release of product.
Testing finished vaccine lots cannot identify all the potential serious problems with vaccines. If it could, it would not matter what shape the factory was in, because you could simply test each lot and throw away any that were bad. The reason FDA plant inspections are so important is because product testing is insufficient to identify potential problems with vaccines.
I clearly recall a GAO report to Congress by Dr. Sushil Sharma about anthrax vaccine (that incidentally had also been made by EBS), which explained this point. What it means is that Janet Woodcock, the acting Commissioner, is attempting to mislead everyone by claiming that with additional testing, the lots produced while the plant was far out of compliance are not adulterated and can still be used.
The regulators in the other nations that received the bad lots of J and J vaccine repeated her identical, fallacious excuse.
While Dr. Woodcock is trying to cover her derriere (probably FDA knew about and approved the shipments of vaccine to other nations) there is no way either the FDA nor Emergent can squirm out of the hole they have dug for themselves.
From the NY Times:
Neither the F.D.A. nor its parent agency, the Department of Health and Human Services, would say what role, if any, the federal government played in the shipment of Johnson & Johnson doses abroad, or when and where they were shipped. White House officials did not respond to repeated requests for comment.
It is strange that after having failed so many prior inspections over 2 decades, Emergent BioSolutions was chosen to lead the US' response to Covid. It is slated to produce 4 vaccines and 5 other Covid medications.
In a statement to The New York Times, an F.D.A. spokeswoman said the agency was “in close communication with our foreign regulatory counterparts regarding this ongoing matter to ensure they’re aware of the situation...”
Does this mean FDA notified them of the May 6 NY Times revelations, informed them the jig was up, and they needed to come up with a uniform story?
Emergent referred questions to Johnson & Johnson and the F.D.A. “They control where the product goes after we manufacture it,” Matt Hartwig, a spokesman for the company, said in an email...
The European Union’s drug regulator, the European Medicines Agency, said in a statement to The Times that one batch of vaccine manufactured at the Emergent facility “is being used” after “a thorough testing of the batch and a review of the controls in place at the manufacturing site.” There is no indication of any problems with those doses.
That batch was distributed for use in the European Union only after meeting “the rigorous quality standards of our company and the European Medicines Agency,” Johnson & Johnson said in a statement...
Under its contract with Johnson & Johnson, Emergent manufactured the active ingredient for the vaccine in bulk, and the substance was then sent to other facilities for final processing and packaging...
The thing is, since Emergent knew it had not passed its inspections, it also knew its product could not be approved for use. So why did it ship it out for final bottling and finishing? Why did J and J collude with them to do so?
Everyone involved in this sordid tale has now gotten burned. It looks like there is plenty of blame to go around. The only thing missing is a prosecution.
The problem is pernicious secrecy. EBS, J and J, FDA and most likely the regulatory agencies of the EU, Canada, Mexico and South Africa had to have known there were problems with this vaccine. But they chose instead to look the other way, until their charade was uncovered by the New York Times.
And even after recipients started dying from blood clots and bleeding, the regulators, EBS and Johnson and Johnson kept the truth of the substandard vaccine they had released for use close to their chests.
And now the government regulators are still trying to fake us out by fancifully claiming they can test their way out of this. These same duplicitous apparatchiks were perfectly willing to inject trash into the arms of millions of their fellow citizens.
And already in Canada, and next week in the US, it might be injected into the waiting arms of 12 to 15 year olds.
Posted by Meryl Nass, M.D. at 12:36 AM 2 comments
Thursday, May 6, 2021
von der Leyen and the 4.1 billion doses/ NY Times
I am a week late getting this NYT article out. While the Times hints that von der Leyen bought the Pfizer vaccine for her political survival, the paper provides no evidence. My guess is that this is a cover story. You have to explain 4.1 billion doses for 448 million people some way. Politics is easy to blame.
The new contract will include a 900-million-dose order through 2023, with an option for another 900 million, Ms. von der Leyen said in an interview.
“I am convinced that we are in this for the long haul,” she said...
Accounts of how the deals came about, related by Ms. von der Leyen, Mr. Bourla, Mr. Marett and another nine officials and experts involved, reveal a striking alignment of political survival and corporate hustle...
Mr. Bourla said he built a bond with Ms. von der Leyen...
Mr. Bourla said he expected a booster would be needed six to twelve months after people get their second shot, although some public health experts note that it is not clear yet whether that will be necessary. And the assessment includes a worst-case scenario for a new vaccine to target an “escape mutant,” a variant of the coronavirus that is too resistant to existing shots. The draft says the European Union would require 640 million doses of this type of vaccine for two doses per adult...
Ms. von der Leyen said the European Union could still procure doses from other companies. [Yet more vaccine???]
She said the bloc was following the development of protein-based vaccines made by Novavax and Sanofi, as well as mRNA vaccines from Moderna, which are already being used in Europe, and CureVac, which is under review by the E.U. regulator. The Johnson & Johnson vaccine, which was rolled out in Europe this month, is also attractive because of its single-dose regimen and easy storage, she said.
The Pfizer shot is also expensive. While the financial details of the new agreement have not been disclosed, the previous contract priced the shot at approximately 15.5 euros, or about 19 dollars, making it the second-most expensive vaccine in the region after Moderna.
European Union members will each decide whether they want to use their full allocations of doses, or leave some for others to absorb, or to be resold or donated. They will also be free to make bilateral agreements with other pharmaceutical companies for vaccines in the future... [And even more possible vaccine]
Posted by Meryl Nass, M.D. at 9:11 PM 0 comments
It just makes sense: no Covid vaccine mandates until we actually know how safe the vaccine is, especially in the young/ Maine legislature
https://www.billtrack50.com/BillDetail/1338397
ME LD867
An Act To Prohibit Mandatory COVID-19 Vaccinations for 5 Years To Allow for Safety Testing and Investigations into Reproductive Harm
Views:
In the last
101
WEEK
86
MONTH
147
TOTAL
SUMMARY
BILL TEXT
ACTIONS
VOTES
DOCUMENTS
summary
Introduced
03/10/2021In Committee
03/10/2021Crossed OverPassedDead/Failed
Introduced Session
130th Legislature
Bill Summary
This bill prohibits mandatory vaccinations for coronavirus disease 2019 for 5 years from the date of a vaccine's first emergency use authorization by the United States Department of Health and Human Services, Food and Drug Administration in order to allow for safety testing and investigations into reproductive harm.
Subject
Health Care Services
Sponsors (8)
Tracy Quint (R)*, Susan Bernard (R), Amanda Collamore (R), Jonathan Connor (R), Joshua Morris (R), Heidi Sampson (R), Peggy Stanley (R), Harold Stewart (R),
Last Action
Carried over, in the same posture, to a subsequent special or regular session of the 130th Legislature, pursuant to Joint Order SP 435. (on 03/30/2021)
Official Document
http://legislature.maine.gov/legis/bill ... 7&snum=130
Posted by Meryl Nass, M.D. at 8:44 PM 0 comments